Integral Molecular, a leader in antibody discovery and characterization, has published new research in the journal mAbs, revealing that as many as one-third of antibody-based drugs exhibit nonspecific ...

“Combining our technology with Revvity’s creates a novel in vitro drug discovery solution with the ability to conduct unbiased comparisons through evaluation of multiple tissue types in the same ...